Showing results (821-830 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|April 22, 2022
In Silico Optimized Stapled Peptides Targeting WASF3 in Breast CancerAmeya J Limaye, George N Bendzunas, Matthew K Whittaker, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Discovery of 5-Aryl-2,4-diaminopyrimidine Compounds as Potent and Selective IRAK4 InhibitorsYan Chen, Rajinder Singh, Nan Lin, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Identification of Slow-Binding Inhibitors of the BoNT/A ProteaseEalin N Patel, Lewis D Turner, Mark S Hixon, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
SiRNAs with Neutral Phosphate Triester Hydrocarbon Tails Exhibit Carrier-Free Gene-Silencing ActivityMatthew L Hammill, Kouta Tsubaki, Lidya Salim, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
A Stepwise Targeting Curcumin Derivative, Ser@TPP@CUR, for Acute Kidney InjuryXia Yan, Xue-Ying Tan, Yi-Xuan Li, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Discovery of Highly Potent Serotonin 5-HT2 Receptor Agonists Inspired by Heteroyohimbine Natural ProductsMeghan J Orr, Andrew B Cao, Charles Tiancheng Wang, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Identification and In Silico Binding Study of a Highly Potent DENV NS2B-NS3 Covalent InhibitorXincheng Lin, Jiawei Cheng, Yuming Wu, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Stereochemical Effects on the Antimicrobial Properties of Tetrasubstituted 2,5-DiketopiperazinesThomas M Grant, David Rennison, Alexandra L Krause, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
The Ukrainian Factor in Early-Stage Drug Discovery in the Context of Russian Invasion: The Case of Enamine LtdIvan S Kondratov, Yurii S Moroz, Oleksandr O Grygorenko, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical StudiesJoshua S Alford, John W Lampe, Dorothy Brach, et al.
Pageof 438